{
    "title": "Novartis wins U.S. approval for targeted cancer drug combination",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10945225/Novartis-wins-U-S-approval-targeted-cancer-drug-combination.html",
    "date": "2022-06-23",
    "keywords": [
        "drug",
        "combination",
        "approval",
        "treatment",
        "mutation",
        "braf",
        "v600",
        "cancer",
        "trial",
        "use",
        "tumours",
        "contributor",
        "childhood",
        "brain",
        "driver",
        "business",
        "frankfurt",
        "june",
        "novartis",
        "range",
        "approach",
        "tumour",
        "food",
        "administration",
        "thursday",
        "mekinist",
        "confirmatory",
        "drugmaker",
        "statement",
        "month",
        "promise",
        "subgroup",
        "gliomas",
        "lgg",
        "pill",
        "skin",
        "lung",
        "change",
        "growth",
        "oncology",
        "area",
        "group",
        "development",
        "sale",
        "sandoz",
        "body",
        "rarity",
        "bayer",
        "reporting",
        "burger",
        "jane",
        "merriman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}